Evidence map›Paper›PMID 33472773›Full record

ArticleBMJ open2021

Protocol for a non-randomised feasibility study evaluating a codesigned patient safety guide in primary care.

Rebecca L Morris, Kay Gallacher, Mark Hann, Carly Rolfe, Nicola Small, Sally J Giles, Caroline Sanders, Stephen M Campbell

Abstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Involving patients and carers in patient safety in primary care: A qualitative study of a co-designed patient safety guide.Health expectations : an international journal of public participation in health care and health policy · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rebecca L MorrisNIHR Greater Manchester Patient Safety Translational Research Centre, The University of Manchester, Manchester, UK rebecca.morris@manchester.ac.uk.ORCID 0000-0003-1587-0802
Kay GallacherManchester, UK.
Mark HannCentre for Biostatistics and Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Carly RolfeNIHR Greater Manchester Patient Safety Translational Research Centre, The University of Manchester, Manchester, UK.
Nicola SmallThe University of Manchester, Manchester, UK.ORCID 0000-0002-7879-7967
Sally J GilesNIHR Greater Manchester Patient Safety Translational Research Centre, The University of Manchester, Manchester, UK.
Caroline SandersNIHR Greater Manchester Patient Safety Translational Research Centre, The University of Manchester, Manchester, UK.
Stephen M CampbellNIHR Greater Manchester Patient Safety Translational Research Centre, The University of Manchester, Manchester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatients and carers should be active partners in patient safety with healthcare professionals and be empowered to use personalised approaches to identify safety concerns and work together to prevent them. This protocol paper details a study to examine the feasibility of a multicomponent intervention to involve patients and/or carers in patient safety in primary care in the UK. METHODS AND ANALYSIS: This is a two-phase, non-randomised feasibility mixed methods pragmatic study of a patient safety guide for primary care (PSG-PC). 8 general practices will recruit 120 patient and/or carer participants. All patient and/or carer participants will receive the PSG-PC. It will examine the feasibility and acceptability of the PSG-PC in primary care settings in patients aged 18 years or older who attend appointments at general practice with health professionals four or more times per year as either patients or carers. It will identify secondary outcomes for improving patient safety, health status and patient empowerment, and reducing health service utilisation over 6 months between baseline and 6-month follow-ups. The findings will inform whether a main effectiveness trial is feasible and, if so, how it should be designed, and how many patients and practices will be needed. The study will be undertaken between January 2020 and September 2021. ETHICS AND DISSEMINATION: Ethical approval was obtained from the National Health Service London-West London and Gene Therapy Advisory Committee Research Ethics Committee (reference: 19/LO/1289). Research findings will be disseminated with participating general practices and shared in a range of different ways to engage different audiences, including presenting at international and national conferences, publishing in open-access, peer-reviewed journals and facilitating dissemination workshops within local communities with patients, carers and healthcare professionals. TRIAL REGISTRATION NUMBER: ISRCTN90222092.

Indexed as

Patient SafetyState MedicineAdolescentFeasibility StudiesHumansLondonPrimary Health Careeducation & training (see medical education & training)primary carequality in health care

Identifiers

PMID33472773
PMCPMC7818830

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.